Inventor · disambiguated record
Gennady Gololobov
Also filed as: GOLOLOBOV GENNADY
6 granted patents·6 pending applications·45 citations·filing 1998–2025
81Inventor score
Files withCSTONE PHARMACEUTICALS3WUXI BIOLOGICS SHANGHAI CO LTD3WUXI BIOLOGICS IRELAND LTD2PAUL SUDHIR1SMITH LARRY J1
Top patents by PatentIndex Score
12 records- 0195US11078281B2Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)WUXI BIOLOGICS SHANGHAI CO LTD·Filed 2020·Granted Aug 3, 2021·8 cites·7 claims
- 0284US12240906B2Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)WUXI BIOLOGICS SHANGHAI CO LTD·Filed 2023·Granted Mar 4, 2025·0 cites·6 claims
- 0383US11643463B2Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)WUXI BIOLOGIES SHANGHAI CO LTD·Filed 2017·Granted May 9, 2023·3 cites·4 claims
- 0475US6235714B1Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their usesFiled 1998·Granted May 22, 2001·30 cites·13 claims
- 0573US2024101676A1The novel monoclonal antibodies to programmed death 1 (pd-1)CSTONE PHARMACEUTICALS·Filed 2023·Application pending·0 cites
- 0672US11414487B2Monoclonal antibodies to programmed death 1 (PD-1)CSTONE PHARMACEUTICALS·Filed 2016·Granted Aug 16, 2022·1 cites·18 claims
- 0772US2025163156A1Novel monoclonal antibodies to cytotoxic t-lymphocyte-associated protein 4 (ctla-4)WUXI BIOLOGICS SHANGHAI CO LTD·Filed 2025·Application pending·0 cites
- 0868US6855528B2Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their usesSMITH LARRY J·Filed 2001·Granted Feb 15, 2005·3 cites·4 claims
- 0967US2023014722A1Novel Monoclonal Antibodies to Programmed DEATH (PD-1)CSTONE PHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 1055US2023391846A1Modified soluble t cell receptorWUXI BIOLOGICS IRELAND LTD·Filed 2021·Application pending·0 cites
- 1151US2005214295A1Combined chemotherapy compositions and methods for the treatment of cancer, ischemia-reperfusion injury, and septic shockPAUL SUDHIR·Filed 2005·Application pending·0 cites
- 1236US2020165354A1Novel Anti-PCSK9 AntibodiesWUXI BIOLOGICS IRELAND LTD·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →